Avascular Osteonecrosis and Accompanying Anemia, Leucocytosis, and Decreased Bone Mineral Density in Renal Transplant Recipients

被引:8
|
作者
Paydas, S. [1 ]
Balal, M. [1 ]
Demir, E. [2 ]
Sertdemir, Y. [3 ]
Erken, U. [2 ]
机构
[1] Cukurova Univ, Dept Nephrol, Fac Med, TR-01330 Adana, Turkey
[2] Cukurova Univ, Dept Urol, Fac Med, TR-01330 Adana, Turkey
[3] Cukurova Univ, Dept Biostat, Fac Med, TR-01330 Adana, Turkey
关键词
FEMORAL-HEAD; ALLOGRAFT RECIPIENTS; NECROSIS; HIP;
D O I
10.1016/j.transproceed.2011.02.072
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Avascular osteonecrosis (AVN) is a complication of renal transplantation. In this study, we present 12 cases of AVN associated with renal transplantation. Methods. Renal transplant recipients (RTRs) with AVN (group I [GI]) were evaluated by using magnetic resonance imaging and blood urea nitrogen, creatinine, glucose, calcium, phosphorus, magnesium, alkaline phosphatase, parathyroid hormone, and urine analysis. We evaluated bone mineral density (BMD) of the femoral neck and lumbar vertebrae. All patients were treated with steroids, cyclosporine, or tacrolimus plus mycophenolate mofetil. Twenty-six RTRs (GII) without AVN were randomly selected as control subjects. Results. The mean ages of GI and GII, were 33.81 +/- 6.72 and 34.00 +/- 7.65 years respectively (P > .05). The mean interval between transplantation and development of AVN was 12.08 +/- 6.48 months. Although levels of blood urea nitrogen, creatinine, calcium, magnesium, and parathyroidhormone, as well as glucocorticoid doses in the first 12 months were similar in GI and GII, there were significant differences in serum alkaline phosphatase, hemoglobin levels, and white blood cell count between GI and GII (P < .05 for each). BMD T score <-1.5 was observed in 8/9 GI and 15/26 patients in GII. All of the patients with AVN except 1, were followed with conservative measures including calcium, magnesium, and vitamin D replacement therapies, bisphosphonate, and reduced or ceased glucocorticoid treatment. Although T scores of the femoral head were similar in GI and GII, the lumbar vertebral T score was significantly lower in GI than in GII (P < .052). Conclusion. AVN developed within the first year after transplantation. Decreased lumbar vertebral BMD, which can be an indicator of glucocorticoid effect, accompanied AVN in nearly all patients. Despite the absence of renal dysfunction, increased bone destruction, anemia, and leucocytosis were coincidental or accompanying findings in our patients with AVN.
引用
收藏
页码:863 / 866
页数:4
相关论文
共 50 条
  • [41] BONE MINERAL DENSITY IN LONG-TERM RENAL TRANSPLANT RECIPIENTS: THE INFLUENCE OF SEX HORMONES AND GENDER
    Brandenburg, Vincent M.
    Westenfeld, Ralf
    Ketteler, Markus
    Frank, Rolf Dario
    Floege, Jurgen
    NEPHROLOGY, 2005, 10 : A93 - A93
  • [42] Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density
    Farmer, C. K. T.
    Hampson, G.
    Abbs, I. C.
    Hilton, R. M.
    Koffman, C. G.
    Fogelman, I.
    Sacks, S. H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) : 2929 - 2936
  • [43] Efficacy of denosumab on bone metabolism and bone mineral density in renal transplant recipients: A systematic review and meta-analysis
    Zhu, Peiqin
    Yang, Tong
    Le, Jun
    Fu, Xiaoting
    Zhang, Liang
    TRANSPLANTATION REVIEWS, 2023, 37 (04)
  • [44] Anemia in pediatric renal transplant recipients
    Joshua Yehuda Kausman
    Harley Robert Powell
    Colin Lindsay Jones
    Pediatric Nephrology, 2004, 19 : 526 - 530
  • [45] ANEMIA IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
    Kahveci, Ahmet
    Ozcakar, Z. Birsin
    Cakar, Nilgun
    Erdogan, Beyza Doganay
    Yalcinkaya, Fatos
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1949 - 1950
  • [46] Causes of anemia in renal transplant recipients
    Karakus, S
    Kanbay, M
    Köseoglu, HK
    Çolak, T
    Haberal, M
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (01) : 164 - 165
  • [47] Anemia in pediatric renal transplant recipients
    Kausman, JY
    Powell, HR
    Jones, CL
    PEDIATRIC NEPHROLOGY, 2004, 19 (05) : 526 - 530
  • [48] CONTINUING LOSS OF VERTEBRAL MINERAL DENSITY IN RENAL-TRANSPLANT RECIPIENTS
    BAGNI, B
    GILLI, P
    CAVALLINI, A
    BAGNI, I
    MARZOLA, MC
    ORZINCOLO, C
    WAHNER, HW
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (02): : 108 - 112
  • [49] LOW BONE MINERAL DENSITY PREDICTS FRACTURE IN KIDNEY TRANSPLANT RECIPIENTS
    Jorgensen, Hanne Skou
    Eide, Ivar
    Bollerslev, Jens
    Godang, Kristin
    Midtvedt, Karsten
    Reisaeter, Anna
    Johnsen, Linda
    Hartmann, Anders
    Asberg, Anders
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 293 - 293
  • [50] Improvement of bone mineral density in kidney transplant recipients: it is just denosumab?
    Barbuto, Simona
    Vetrano, Daniele
    Speciale, Serena
    Aguanno, Francesco
    Comai, Giorgia
    La Manna, Gaetano
    Cianciolo, Giuseppe
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1667 - I1669